Treatment management of cancer patients in the radiation oncology departments during the current COVID-19 pandemic is challenging. A systematic review of published consensus/guidelines on the role of radiotherapy prioritization, suggested treatment protocols, and set up management was undertaken based on the PRISMA protocol and through PubMed/PMC, Scopus, Google Scholar, Web of Science databases until 01/20/2021. One hundred and sixty-eight publications or regional consensus were included. Summary of recommendations contained: (1) using hypo-fractionated (Hypo-F) regimens for therapeutic/palliative indications, (2) delaying radiotherapy for several weeks or until pandemic over, (3) omitting radiotherapy by replacement of alternative therapies or active surveillance, (4) applying safer patients' setup and preparation protocols, (5) developing telemedicine/telehealth service. To conclude, it is essential to carefully weigh the risk of exposure to COVID-19 infection and the benefit of treating cancer patients during the pandemic. Trying to have a global guideline facing this or any other probable crisis is crucial for health care service.

当前 COVID-19 大流行期间，放射肿瘤科癌症患者的治疗管理面临挑战。截至 20 月 1 日，基于 PRISMA 协议并通过 PubMed/PMC、Scopus、Google Scholar、Web of Science 数据库对已发布的关于放疗优先顺序、建议治疗方案和设置管理的共识/指南进行了系统回顾2021 年。其中包括一百六十八份出版物或区域共识。建议摘要包含：(1) 使用大分割 (Hypo-F) 方案治疗/姑息治疗，(2) 将放疗推迟数周或直至大流行结束，(3) 通过替代替代疗法或主动监测来省略放疗，(4) 应用更安全的患者设置和准备方案，(5) 开发远程医疗/远程医疗服务。总之，必须仔细权衡接触 COVID-19 感染的风险以及在大流行期间治疗癌症患者的益处。尝试制定一个全球指南来应对这场危机或任何其他可能的危机对于医疗保健服务至关重要。